Oneness Biotech Co., Ltd. (TPEX:4743)

Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,852	1,048	812.83	5,655	332.96	217.64
Short-Term Investments	2,942	5,971	6,960	2,392	7,473	8,099
Cash & Short-Term Investments	5,794	7,019	7,773	8,047	7,806	8,317
Cash Growth	-23.21%	-9.70%	-3.40%	3.08%	-6.14%	423.69%
Accounts Receivable	19.7	18.34	25.77	13.08	14.59	444.45
Other Receivables	88.47	77.88	50.77	19.86	114.2	70.37
Receivables	108.17	96.22	76.54	32.95	128.79	514.82
Inventory	110.45	115.16	122.74	111.4	81.32	50.19
Other Current Assets	65	62.83	45.93	42.2	35.31	55.31
Total Current Assets	6,077	7,293	8,018	8,233	8,051	8,937
Property, Plant & Equipment	1,055	1,106	1,195	1,033	1,038	1,046
Long-Term Investments	3,178	3,737	4,096	3,920	3,871	2,585
Goodwill	-	57.44	89.14	89.14	89.14	89.14
Other Intangible Assets	1,088	1,125	1,682	2,010	2,388	2,474
Long-Term Accounts Receivable	-	-	-	-	32.41	32.94
Long-Term Deferred Tax Assets	168.65	137.57	79.21	97.46	62.85	38.67
Other Long-Term Assets	215.63	204.05	204.05	197.65	197.86	180.73
Total Assets	11,782	13,660	15,364	15,580	15,731	15,384
Accounts Payable	1.62	2.73	1.7	1.52	2.5	48.43
Accrued Expenses	-	103.57	119.05	155.39	78.16	58.6
Current Portion of Leases	44.73	41.18	34.25	13.25	12.73	23.23
Current Income Taxes Payable	-	0.12	0.12	12.69	35.1	-
Other Current Liabilities	119.59	35.32	60.24	25.76	28.75	23.44
Total Current Liabilities	165.95	182.92	215.36	208.6	157.24	153.69
Long-Term Leases	359.09	365.18	397.95	250.09	270.34	279.86
Long-Term Unearned Revenue	170.33	170.68	176.07	145.99	1,155	1,155
Long-Term Deferred Tax Liabilities	160.78	140.41	76.56	95.22	58.18	35.09
Other Long-Term Liabilities	0.47	0.47	0.48	0.48	0.48	0.48
Total Liabilities	856.62	859.65	866.43	700.38	1,642	1,625
Common Stock	4,795	4,791	4,545	3,910	3,853	3,771
Additional Paid-In Capital	6,485	7,623	9,050	8,637	9,469	9,157
Retained Earnings	-1,003	-1,154	-1,267	359.98	-1,036	-633.57
Treasury Stock	-25.78	-25.78	-25.78	-25.78	-47.38	-75.81
Comprehensive Income & Other	210.78	1,066	1,750	1,737	1,778	1,415
Total Common Equity	10,461	12,299	14,053	14,618	14,016	13,633
Minority Interest	464.43	501.02	444.07	262.28	72.95	126.38
Shareholders' Equity	10,926	12,800	14,497	14,880	14,089	13,760
Total Liabilities & Equity	11,782	13,660	15,364	15,580	15,731	15,384
Total Debt	403.83	406.35	432.2	263.34	283.07	303.09
Net Cash (Debt)	5,390	6,613	7,341	7,783	7,523	8,014
Net Cash Growth	-24.29%	-9.92%	-5.69%	3.46%	-6.13%	536.11%
Net Cash Per Share	11.22	13.83	15.50	16.50	16.52	18.80
Filing Date Shares Outstanding	479.66	478.03	476.23	466.02	458.4	447.43
Total Common Shares Outstanding	479.66	478.03	476.23	466.02	458.4	447.43
Working Capital	5,911	7,110	7,803	8,025	7,894	8,784
Book Value Per Share	21.81	25.73	29.51	31.37	30.58	30.47
Tangible Book Value	9,373	11,117	12,282	12,519	11,539	11,070
Tangible Book Value Per Share	19.54	23.26	25.79	26.86	25.17	24.74
Buildings	-	640.27	637.35	602.54	580.99	510.38
Machinery	-	554.04	547.55	522.99	456.01	399.52
Construction In Progress	-	1.98	18.24	-	13.03	48.15
Leasehold Improvements	-	58.15	27.56	14.56	14.01	9.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.